 Tzu Phang
Concepts (320)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Glucocorticoid | 4 | 2017 | 139 | 0.570 |
Why?
| | Software | 5 | 2013 | 618 | 0.540 |
Why?
| | Gene Expression Profiling | 15 | 2014 | 1640 | 0.530 |
Why?
| | Databases, Genetic | 3 | 2009 | 289 | 0.450 |
Why?
| | Gene Expression Regulation | 9 | 2017 | 2629 | 0.420 |
Why?
| | Chorionic Gonadotropin | 5 | 2000 | 80 | 0.370 |
Why?
| | Mammary Glands, Animal | 3 | 2006 | 182 | 0.360 |
Why?
| | Alternative Splicing | 1 | 2009 | 208 | 0.350 |
Why?
| | Receptors, LH | 4 | 2000 | 6 | 0.340 |
Why?
| | Kruppel-Like Transcription Factors | 2 | 2017 | 54 | 0.320 |
Why?
| | Nuclear Proteins | 3 | 2017 | 649 | 0.310 |
Why?
| | Oligonucleotide Array Sequence Analysis | 12 | 2014 | 835 | 0.300 |
Why?
| | Face | 3 | 2017 | 177 | 0.270 |
Why?
| | Computational Biology | 4 | 2013 | 674 | 0.260 |
Why?
| | Dog Diseases | 2 | 2012 | 44 | 0.220 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 241 | 0.210 |
Why?
| | Precancerous Conditions | 1 | 2021 | 166 | 0.210 |
Why?
| | Hemangiosarcoma | 2 | 2010 | 21 | 0.200 |
Why?
| | Hermanski-Pudlak Syndrome | 1 | 2019 | 2 | 0.200 |
Why?
| | Respiratory System | 2 | 2017 | 140 | 0.190 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2019 | 69 | 0.190 |
Why?
| | Systems Biology | 2 | 2017 | 61 | 0.190 |
Why?
| | Pulmonary Alveoli | 2 | 2012 | 407 | 0.180 |
Why?
| | Database Management Systems | 2 | 2009 | 65 | 0.180 |
Why?
| | Phospholipase C delta | 1 | 2017 | 4 | 0.180 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2017 | 892 | 0.180 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2012 | 1210 | 0.170 |
Why?
| | Airway Remodeling | 1 | 2017 | 59 | 0.170 |
Why?
| | Maxillofacial Development | 1 | 2017 | 24 | 0.170 |
Why?
| | Ectoderm | 1 | 2017 | 53 | 0.160 |
Why?
| | Muscle, Smooth | 1 | 2017 | 143 | 0.160 |
Why?
| | Proteins | 3 | 2000 | 998 | 0.160 |
Why?
| | Cluster Analysis | 4 | 2010 | 490 | 0.160 |
Why?
| | Photoaffinity Labels | 3 | 2000 | 6 | 0.160 |
Why?
| | Mesoderm | 1 | 2017 | 145 | 0.160 |
Why?
| | Pulmonary Fibrosis | 1 | 2019 | 344 | 0.160 |
Why?
| | Transcription Factor RelA | 1 | 2016 | 89 | 0.150 |
Why?
| | DNA Copy Number Variations | 2 | 2021 | 159 | 0.150 |
Why?
| | Saccharopine Dehydrogenases | 1 | 2015 | 2 | 0.150 |
Why?
| | Proline Oxidase | 1 | 2015 | 3 | 0.150 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2017 | 142 | 0.150 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 373 | 0.150 |
Why?
| | Response Elements | 1 | 2015 | 91 | 0.150 |
Why?
| | Fibroblast Growth Factor 8 | 1 | 2014 | 28 | 0.140 |
Why?
| | Cleft Lip | 1 | 2014 | 37 | 0.140 |
Why?
| | Dogs | 3 | 2012 | 472 | 0.140 |
Why?
| | Transcription Factor AP-2 | 1 | 2014 | 85 | 0.140 |
Why?
| | Cleft Palate | 1 | 2014 | 49 | 0.140 |
Why?
| | Gene Expression | 3 | 2016 | 1588 | 0.140 |
Why?
| | Gene Dosage | 1 | 2014 | 148 | 0.140 |
Why?
| | Lung Neoplasms | 2 | 2021 | 2184 | 0.140 |
Why?
| | Gene Regulatory Networks | 3 | 2013 | 231 | 0.130 |
Why?
| | Internet | 2 | 2009 | 633 | 0.130 |
Why?
| | DNA-Binding Proteins | 2 | 2014 | 1460 | 0.130 |
Why?
| | Lactation | 2 | 2006 | 220 | 0.130 |
Why?
| | Introns | 1 | 2014 | 243 | 0.130 |
Why?
| | Antiporters | 2 | 2003 | 21 | 0.130 |
Why?
| | Transcription, Genetic | 3 | 2015 | 1473 | 0.130 |
Why?
| | Lymphoma, T-Cell | 1 | 2012 | 20 | 0.130 |
Why?
| | Mice | 12 | 2021 | 15641 | 0.120 |
Why?
| | Epithelial Cells | 2 | 2016 | 1032 | 0.120 |
Why?
| | Membrane Proteins | 1 | 2019 | 1098 | 0.120 |
Why?
| | Growth Hormone-Secreting Pituitary Adenoma | 1 | 2012 | 11 | 0.120 |
Why?
| | Cell Line | 6 | 2016 | 3016 | 0.120 |
Why?
| | NF-kappa B | 2 | 2014 | 719 | 0.120 |
Why?
| | Iodine Radioisotopes | 5 | 2000 | 131 | 0.120 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 460 | 0.120 |
Why?
| | Lymphoma, B-Cell | 1 | 2012 | 95 | 0.120 |
Why?
| | Transcriptome | 2 | 2017 | 692 | 0.110 |
Why?
| | Animals | 17 | 2021 | 35394 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 416 | 0.110 |
Why?
| | Comparative Genomic Hybridization | 1 | 2010 | 30 | 0.110 |
Why?
| | Databases, Nucleic Acid | 1 | 2010 | 40 | 0.110 |
Why?
| | Philadelphia Chromosome | 1 | 2010 | 21 | 0.110 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2012 | 136 | 0.110 |
Why?
| | Immunity, Innate | 3 | 2012 | 763 | 0.110 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2010 | 70 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2016 | 1123 | 0.100 |
Why?
| | NFATC Transcription Factors | 1 | 2010 | 83 | 0.100 |
Why?
| | Influenza A virus | 1 | 2011 | 106 | 0.100 |
Why?
| | Adenoma | 1 | 2012 | 190 | 0.100 |
Why?
| | Dexamethasone | 3 | 2017 | 319 | 0.100 |
Why?
| | Reoviridae | 1 | 2010 | 42 | 0.100 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 111 | 0.100 |
Why?
| | Down-Regulation | 2 | 2010 | 682 | 0.100 |
Why?
| | Encephalitis, Viral | 1 | 2010 | 58 | 0.100 |
Why?
| | Reoviridae Infections | 1 | 2010 | 62 | 0.100 |
Why?
| | Alcohol-Related Disorders | 1 | 2010 | 120 | 0.100 |
Why?
| | Breeding | 1 | 2009 | 70 | 0.100 |
Why?
| | Wnt Proteins | 1 | 2010 | 155 | 0.100 |
Why?
| | Algorithms | 2 | 2009 | 1558 | 0.090 |
Why?
| | Neovascularization, Pathologic | 1 | 2010 | 291 | 0.090 |
Why?
| | Estrogen Receptor alpha | 1 | 2009 | 113 | 0.090 |
Why?
| | Biomarkers, Tumor | 2 | 2012 | 1045 | 0.090 |
Why?
| | Humans | 26 | 2019 | 113846 | 0.090 |
Why?
| | RNA Polymerase II | 3 | 2017 | 292 | 0.090 |
Why?
| | Sequence Analysis, DNA | 1 | 2011 | 798 | 0.090 |
Why?
| | Blood Platelets | 1 | 2010 | 388 | 0.080 |
Why?
| | Data Collection | 1 | 2010 | 672 | 0.080 |
Why?
| | Pregnenolone Carbonitrile | 1 | 2006 | 3 | 0.080 |
Why?
| | Macrophages, Alveolar | 1 | 2010 | 371 | 0.080 |
Why?
| | Bacterial Proteins | 2 | 2003 | 759 | 0.080 |
Why?
| | Influenza, Human | 1 | 2012 | 462 | 0.080 |
Why?
| | Receptors, Steroid | 1 | 2006 | 57 | 0.080 |
Why?
| | Sleep | 1 | 2013 | 710 | 0.080 |
Why?
| | Models, Statistical | 1 | 2010 | 693 | 0.080 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 3118 | 0.080 |
Why?
| | Neoadjuvant Therapy | 1 | 2008 | 288 | 0.080 |
Why?
| | Tumor Necrosis Factor alpha-Induced Protein 3 | 2 | 2016 | 8 | 0.080 |
Why?
| | Up-Regulation | 2 | 2006 | 975 | 0.070 |
Why?
| | Inflammation | 2 | 2014 | 2451 | 0.070 |
Why?
| | Cell Nucleus | 1 | 2008 | 626 | 0.070 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2008 | 386 | 0.070 |
Why?
| | Macrophages | 1 | 2012 | 1343 | 0.070 |
Why?
| | RNA, Messenger | 6 | 2010 | 2857 | 0.070 |
Why?
| | Mutagenesis | 3 | 2002 | 185 | 0.070 |
Why?
| | Saccharomyces cerevisiae | 1 | 2008 | 546 | 0.070 |
Why?
| | Alcoholism | 1 | 2010 | 801 | 0.070 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 5249 | 0.070 |
Why?
| | Protein Binding | 3 | 2016 | 2115 | 0.070 |
Why?
| | Lung | 2 | 2010 | 3637 | 0.070 |
Why?
| | Calcium | 1 | 2010 | 1217 | 0.070 |
Why?
| | Hemangioma, Cavernous | 1 | 2003 | 17 | 0.060 |
Why?
| | Transcription Factors | 2 | 2009 | 1643 | 0.060 |
Why?
| | Intracranial Arteriovenous Malformations | 1 | 2003 | 25 | 0.060 |
Why?
| | Signal Transduction | 6 | 2015 | 4923 | 0.060 |
Why?
| | Tetracycline Resistance | 1 | 2002 | 3 | 0.060 |
Why?
| | Female | 14 | 2021 | 63035 | 0.060 |
Why?
| | Models, Biological | 3 | 2012 | 1845 | 0.060 |
Why?
| | Pregnancy, Animal | 1 | 2003 | 75 | 0.060 |
Why?
| | Sequence Analysis, RNA | 2 | 2017 | 401 | 0.060 |
Why?
| | Lipid Metabolism | 1 | 2006 | 538 | 0.060 |
Why?
| | Genomics | 1 | 2007 | 626 | 0.060 |
Why?
| | Cell Membrane | 2 | 2006 | 771 | 0.060 |
Why?
| | Mitochondria | 1 | 2008 | 810 | 0.060 |
Why?
| | Laser Capture Microdissection | 1 | 2021 | 26 | 0.060 |
Why?
| | Cells, Cultured | 4 | 2017 | 4429 | 0.060 |
Why?
| | Statistics, Nonparametric | 1 | 2003 | 463 | 0.060 |
Why?
| | Binding Sites | 4 | 2015 | 1323 | 0.060 |
Why?
| | Whole Genome Sequencing | 1 | 2021 | 104 | 0.060 |
Why?
| | Mutation | 3 | 2021 | 3447 | 0.050 |
Why?
| | Brain | 2 | 2013 | 2686 | 0.050 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2015 | 446 | 0.050 |
Why?
| | Amino Acid Sequence | 3 | 2003 | 2229 | 0.050 |
Why?
| | Liver | 2 | 2006 | 1867 | 0.050 |
Why?
| | STAT1 Transcription Factor | 2 | 2011 | 79 | 0.050 |
Why?
| | Chemokines | 2 | 2012 | 240 | 0.050 |
Why?
| | Blotting, Western | 2 | 2016 | 1316 | 0.050 |
Why?
| | Base Sequence | 2 | 2015 | 2321 | 0.050 |
Why?
| | Breast Neoplasms | 2 | 2009 | 1909 | 0.050 |
Why?
| | Frameshift Mutation | 1 | 2019 | 29 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2016 | 1251 | 0.050 |
Why?
| | Models, Genetic | 1 | 2003 | 661 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 909 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2021 | 1100 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2021 | 3910 | 0.040 |
Why?
| | Pregnancy | 3 | 2006 | 5290 | 0.040 |
Why?
| | Hypertrophy | 1 | 2017 | 120 | 0.040 |
Why?
| | Promoter Regions, Genetic | 2 | 2015 | 1259 | 0.040 |
Why?
| | Cross-Linking Reagents | 1 | 1998 | 195 | 0.040 |
Why?
| | Jaw | 1 | 2017 | 21 | 0.040 |
Why?
| | Haplotypes | 1 | 2019 | 547 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2019 | 324 | 0.040 |
Why?
| | Apoptosis | 3 | 2014 | 2675 | 0.040 |
Why?
| | Transduction, Genetic | 1 | 2017 | 133 | 0.040 |
Why?
| | Nose | 1 | 2017 | 55 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2017 | 167 | 0.040 |
Why?
| | Adenoviridae | 1 | 2017 | 194 | 0.040 |
Why?
| | Tongue | 1 | 2017 | 86 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2017 | 294 | 0.040 |
Why?
| | Acetic Acid | 1 | 1996 | 13 | 0.040 |
Why?
| | Autoradiography | 1 | 1996 | 82 | 0.040 |
Why?
| | Hypoxia | 1 | 2003 | 940 | 0.040 |
Why?
| | Indicators and Reagents | 1 | 1996 | 116 | 0.040 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2015 | 86 | 0.040 |
Why?
| | Acetates | 1 | 1996 | 106 | 0.040 |
Why?
| | Brain Neoplasms | 1 | 2003 | 960 | 0.040 |
Why?
| | Exons | 2 | 2010 | 317 | 0.040 |
Why?
| | Cell Proliferation | 2 | 2014 | 2404 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2017 | 468 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2017 | 694 | 0.030 |
Why?
| | In Situ Hybridization | 1 | 2014 | 342 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 515 | 0.030 |
Why?
| | Prognosis | 2 | 2012 | 3544 | 0.030 |
Why?
| | Bronchi | 1 | 2015 | 242 | 0.030 |
Why?
| | Enkephalins | 1 | 2013 | 19 | 0.030 |
Why?
| | Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2013 | 12 | 0.030 |
Why?
| | Prealbumin | 1 | 2013 | 22 | 0.030 |
Why?
| | Education | 1 | 2013 | 110 | 0.030 |
Why?
| | Cartilage | 1 | 2014 | 183 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 2 | 2010 | 858 | 0.030 |
Why?
| | Male | 8 | 2013 | 60993 | 0.030 |
Why?
| | Myosins | 1 | 2013 | 131 | 0.030 |
Why?
| | Cytokines | 2 | 2012 | 1981 | 0.030 |
Why?
| | RNA, Neoplasm | 1 | 2012 | 97 | 0.030 |
Why?
| | Bone and Bones | 1 | 2014 | 252 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2010 | 2936 | 0.030 |
Why?
| | Protein Precursors | 1 | 2013 | 132 | 0.030 |
Why?
| | Lectins, C-Type | 1 | 2012 | 75 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 461 | 0.030 |
Why?
| | Exome | 1 | 2013 | 215 | 0.030 |
Why?
| | Middle Aged | 5 | 2012 | 28753 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2014 | 376 | 0.030 |
Why?
| | Immunophenotyping | 1 | 2012 | 310 | 0.030 |
Why?
| | Protein Structure, Secondary | 2 | 2003 | 399 | 0.030 |
Why?
| | DNA Mutational Analysis | 2 | 2003 | 420 | 0.030 |
Why?
| | Alleles | 1 | 2014 | 905 | 0.030 |
Why?
| | Models, Molecular | 3 | 2003 | 1604 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2016 | 539 | 0.030 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2010 | 13 | 0.030 |
Why?
| | Genes, Neoplasm | 1 | 2010 | 22 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2010 | 91 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2012 | 682 | 0.030 |
Why?
| | Tumor Suppressor Proteins | 1 | 2013 | 297 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 366 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 454 | 0.030 |
Why?
| | Dasatinib | 1 | 2010 | 43 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2010 | 89 | 0.030 |
Why?
| | Caspases, Effector | 1 | 2010 | 2 | 0.030 |
Why?
| | Imatinib Mesylate | 1 | 2010 | 68 | 0.030 |
Why?
| | Surface-Active Agents | 1 | 2011 | 98 | 0.030 |
Why?
| | Markov Chains | 1 | 2010 | 127 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2010 | 182 | 0.030 |
Why?
| | Fibroblasts | 1 | 2015 | 906 | 0.030 |
Why?
| | Interferon Regulatory Factors | 1 | 2010 | 33 | 0.030 |
Why?
| | Thiazoles | 1 | 2010 | 123 | 0.030 |
Why?
| | Amino Acid Motifs | 2 | 2000 | 214 | 0.030 |
Why?
| | Phagocytosis | 1 | 2012 | 386 | 0.030 |
Why?
| | Cyclosporine | 1 | 2010 | 186 | 0.030 |
Why?
| | ras Proteins | 1 | 2010 | 155 | 0.030 |
Why?
| | Demography | 1 | 2010 | 294 | 0.030 |
Why?
| | Inheritance Patterns | 1 | 2009 | 42 | 0.020 |
Why?
| | Benzamides | 1 | 2010 | 186 | 0.020 |
Why?
| | Quality Control | 1 | 2009 | 176 | 0.020 |
Why?
| | Amino Acid Substitution | 2 | 2000 | 309 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2009 | 69 | 0.020 |
Why?
| | Organ Specificity | 1 | 2009 | 310 | 0.020 |
Why?
| | Interferons | 1 | 2010 | 135 | 0.020 |
Why?
| | RNA Splicing | 1 | 2010 | 243 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2009 | 251 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2013 | 775 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2011 | 352 | 0.020 |
Why?
| | Blotting, Northern | 1 | 2008 | 225 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 2074 | 0.020 |
Why?
| | Estrogen Receptor Modulators | 1 | 2008 | 22 | 0.020 |
Why?
| | Perilipin-1 | 1 | 2008 | 20 | 0.020 |
Why?
| | S100 Proteins | 1 | 2008 | 41 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2012 | 1226 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 474 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 2 | 2006 | 3027 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2010 | 1041 | 0.020 |
Why?
| | Cell Communication | 1 | 2009 | 284 | 0.020 |
Why?
| | Kinetics | 1 | 2012 | 1800 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 616 | 0.020 |
Why?
| | Piperazines | 1 | 2010 | 325 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2010 | 608 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2010 | 655 | 0.020 |
Why?
| | Ethanol | 1 | 2013 | 714 | 0.020 |
Why?
| | Adult | 4 | 2012 | 31979 | 0.020 |
Why?
| | Biomedical Research | 1 | 2013 | 609 | 0.020 |
Why?
| | Curriculum | 1 | 2013 | 818 | 0.020 |
Why?
| | Tamoxifen | 1 | 2008 | 201 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2009 | 344 | 0.020 |
Why?
| | Pyrimidines | 1 | 2010 | 402 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2012 | 1141 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 603 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2010 | 1184 | 0.020 |
Why?
| | Phenotype | 1 | 2014 | 3050 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2009 | 421 | 0.020 |
Why?
| | Chromatin | 1 | 2009 | 435 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2010 | 676 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2008 | 335 | 0.020 |
Why?
| | Membrane Transport Proteins | 1 | 2006 | 162 | 0.020 |
Why?
| | Quantitative Trait Loci | 1 | 2007 | 329 | 0.020 |
Why?
| | Time Factors | 2 | 2009 | 7060 | 0.020 |
Why?
| | Research Design | 1 | 2011 | 913 | 0.020 |
Why?
| | Rats | 2 | 2006 | 6387 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2008 | 399 | 0.020 |
Why?
| | Dietary Fats | 1 | 2006 | 356 | 0.020 |
Why?
| | Sequence Analysis, Protein | 1 | 2003 | 41 | 0.020 |
Why?
| | Milk Proteins | 1 | 2003 | 46 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2008 | 824 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1831 | 0.020 |
Why?
| | Osteopontin | 1 | 2003 | 41 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2008 | 681 | 0.020 |
Why?
| | Stromal Cells | 1 | 2003 | 118 | 0.020 |
Why?
| | Sulfhydryl Reagents | 1 | 2002 | 11 | 0.020 |
Why?
| | Corpus Callosum | 1 | 2003 | 58 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2011 | 1842 | 0.020 |
Why?
| | Temporal Arteries | 1 | 2003 | 43 | 0.020 |
Why?
| | Sialoglycoproteins | 1 | 2003 | 185 | 0.020 |
Why?
| | Temporal Lobe | 1 | 2003 | 94 | 0.020 |
Why?
| | Cohort Studies | 1 | 2012 | 5011 | 0.020 |
Why?
| | Disease Progression | 1 | 2010 | 2489 | 0.010 |
Why?
| | Smoking | 1 | 2011 | 1632 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2009 | 2905 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 1397 | 0.010 |
Why?
| | Frontal Lobe | 1 | 2003 | 168 | 0.010 |
Why?
| | Plasmids | 1 | 2002 | 395 | 0.010 |
Why?
| | Cysteine | 1 | 2002 | 207 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2002 | 576 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2006 | 2161 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 906 | 0.010 |
Why?
| | Serine | 1 | 2000 | 133 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2000 | 226 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2424 | 0.010 |
Why?
| | Tyrosine | 1 | 2000 | 244 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2000 | 290 | 0.010 |
Why?
| | Lipids | 1 | 2003 | 629 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2011 | 6796 | 0.010 |
Why?
| | Gene Deletion | 1 | 2000 | 390 | 0.010 |
Why?
| | Aged | 2 | 2011 | 20109 | 0.010 |
Why?
| | Escherichia coli | 1 | 2002 | 812 | 0.010 |
Why?
| | Protein Conformation | 1 | 2000 | 974 | 0.010 |
Why?
| | Pulmonary Artery | 1 | 2003 | 1079 | 0.010 |
Why?
| | Antibodies | 1 | 1998 | 434 | 0.010 |
Why?
| | Young Adult | 1 | 2010 | 10971 | 0.010 |
Why?
| | Hypertension, Pulmonary | 1 | 2003 | 1669 | 0.010 |
Why?
| | Adolescent | 1 | 2003 | 18736 | 0.000 |
Why?
| | Child | 1 | 2003 | 17711 | 0.000 |
Why?
|
|
Phang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|